Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability & Cytotoxicity Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) leverages the water-soluble tetrazolium salt WST-8, which is enzymatically reduced by live-cell dehydrogenases to generate a quantifiable formazan dye, directly correlating with viable cell number (He et al. 2025). The resulting formazan is water-soluble, streamlining the workflow compared to MTT or XTT assays. CCK-8 demonstrates high sensitivity and reproducibility for cell proliferation, viability, and cytotoxicity assessments in diverse biomedical contexts, including osteonecrosis, cancer, and neurodegenerative disease models (Dup753.com). APExBIO's CCK-8 (K1018) kit is validated in peer-reviewed studies and offers superior workflow integration for high-throughput screening. Comparative analyses confirm CCK-8's advantages in sensitivity, dynamic range, and reduced hands-on time (Cellron.com).

Biological Rationale

Cell viability and proliferation are fundamental parameters in biomedical research, underpinning assays for cytotoxicity, drug screening, and disease modeling. Mitochondrial dehydrogenase activity reflects cellular metabolic health and is a widely adopted surrogate for viable cell number. Water-soluble tetrazolium salts, such as WST-8, provide a non-radioactive, colorimetric approach to measure this activity. The Cell Counting Kit-8 (CCK-8), developed and supplied by APExBIO, incorporates WST-8 to enable rapid, direct quantitation of living cells in diverse sample types (Product page). This approach is suitable for high-throughput workflows and is broadly compatible with cancer, neurodegenerative, and metabolic disease research, as recently demonstrated in studies of osteonecrosis of the femoral head (He et al. 2025).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 utilizes the tetrazolium salt WST-8, which is reduced by intracellular NADH-dependent dehydrogenases in metabolically active cells. This reduction produces a water-soluble orange formazan dye. The intensity of the color, measured by absorbance at 450 nm, is directly proportional to the number of viable cells. Unlike MTT and XTT, WST-8 does not require solubilization steps, as the product is inherently water-soluble, eliminating organic solvents and streamlining analysis (GS967.com). The reaction occurs at physiological conditions (37°C, pH 7.2–7.4) and is typically completed within 1–4 hours depending on cell type and density. The sensitivity of the assay allows for detection of as few as 100 viable cells per well in a 96-well format, supporting both low- and high-density applications.

Evidence & Benchmarks

• CCK-8 is validated for quantifying cell viability, proliferation, and cytotoxicity in MC3T3-E1 osteoblastic cells under steroid-induced stress conditions, yielding linear absorbance from 1 × 10² to 1 × 10⁵ cells/well (He et al. 2025).
• WST-8-based CCK-8 outperforms MTT and XTT in sensitivity, dynamic range, and workflow simplicity, requiring no additional solubilization steps (GS967.com).
• In iron overload and oxidative stress models, CCK-8 reliably quantifies changes in cell metabolic activity upon exposure to ferroptosis inducers and inhibitors (Dup753.com).
• High-throughput screening with the K1018 kit demonstrates <2% intra-assay coefficient of variation in 96- and 384-well formats (Product page).
• CCK-8 has been used in vivo for ex vivo cell viability analysis in rat models of osteonecrosis, aligning with micro-CT and histological endpoints (He et al. 2025).

This article extends prior coverage by integrating recent peer-reviewed data and clarifying the mechanistic specificity and translational utility of CCK-8, building upon the workflow-focused analysis in LBBroth.com.

Applications, Limits & Misconceptions

CCK-8 is widely applied for:

• Cell proliferation and cytotoxicity measurement in cancer, neurodegenerative, and metabolic disease models.
• Assessment of drug response in high-throughput screening platforms.
• Monitoring cell survival under oxidative, iron overload, or apoptotic stress conditions.
• Evaluating the efficacy of gene knockdown or overexpression strategies (e.g., SQLE in osteoblasts) (He et al. 2025).

For an in-depth comparison of WST-8-based assays and legacy methods, see Cellron.com, which focuses on translational cardiovascular and cancer research; this article updates that analysis with recent evidence in osteonecrosis and ferroptosis models.

Common Pitfalls or Misconceptions

• Non-specificity for apoptosis vs. necrosis: CCK-8 reports viable cell number but does not distinguish between types of cell death.
• Interference by reducing agents: High concentrations of antioxidants or thiol-containing compounds in media can artificially increase signal.
• Plate edge effects: Evaporation in outer wells of multiwell plates may skew results if not properly controlled.
• Assay window limitations: Extremely high cell densities can saturate the signal, requiring cell titration optimization.
• Not validated for non-adherent cells in suspension without adaptation: The standard protocol assumes cells are attached; suspension cultures may require additional steps.

Workflow Integration & Parameters

The Cell Counting Kit-8 (K1018) protocol involves the following steps:

1. Seed 100–10,000 cells per well in a 96-well plate; incubate overnight at 37°C, 5% CO₂.
2. Add 10 μL of CCK-8 reagent per 100 μL medium per well; avoid bubbles.
3. Incubate for 1–4 hours (cell-type dependent).
4. Read absorbance at 450 nm using a microplate reader.
5. Subtract background (blank wells with medium and reagent only).

Optimal performance requires calibration for cell line, density, and treatment duration. The K1018 kit is compatible with most standard culture media and is stable for at least 6 months at 2–8°C. For advanced applications in cartilage repair or inflammation, see this article, which focuses on tissue-specific adaptations—this article emphasizes disease modeling and high-throughput screening.

Conclusion & Outlook

The APExBIO Cell Counting Kit-8 (CCK-8, SKU K1018) is a validated, sensitive, and user-friendly assay for cell viability and cytotoxicity measurement across disease models. Its water-soluble WST-8 chemistry eliminates tedious solubilization steps, reduces variability, and supports rapid high-throughput workflows. Recent studies confirm its accuracy and reproducibility in both in vitro and ex vivo settings, including challenging models such as steroid-induced osteonecrosis and ferroptosis (He et al. 2025). Continued adoption of CCK-8 will enable precise, scalable assessment of cellular responses, supporting innovations in drug discovery and disease research.